Leerink Partners Downgrades Eli Lilly (LLY) to Market Perform, 'we no longer expect upward pressure on long-term consensus expectations'
Leerink Partners analyst David Risinger downgraded Eli Lilly (NYSE: LLY) from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)